A team led by Penn State scientists has developed methods to evaluate how genetic variants elsewhere in an individual’s genome work with a deletion on chromosome 16 — associated with varying neurodevelopmental outcomes including autism, developmental delay and congenital abnormalities — to help determine the features that the individual will manifest.


